Dietary-induced ERβ upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice

Carcinogenesis

Volumn 31, Issue 2, 2010, Pages 269-274

  Barone, Michele ^a   Tanzi, Sabina ^a   Lofano, Katia ^a   Scavo, Maria Principia ^a   Pricci, Maria ^a   Demarinis, Lucia ^a   Papagni, Samanta ^a   Guido, Raffaella ^a   Maiorano, Eugenio ^b   Ingravallo, Giuseppe ^b   Comelli, Maria Cristina ^c   Francavilla, Antonio ^a   Di Leo, Alfredo ^a  

^a Section of Gastroenterology   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c CM and D Pharma Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ESTROGEN RECEPTOR BETA; LIGNIN; MESSENGER RNA; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; INTESTINE POLYP; LIPID DIET; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR GROWTH; TUMOR VOLUME; ADENOMA; ANIMAL; C57BL MOUSE; DIET; DISEASE MODEL; ENZYME IMMUNOASSAY; GENETICS; INTESTINE TUMOR; METABOLISM; MOUSE MUTANT; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DIET; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR BETA; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INTESTINAL NEOPLASMS; INTESTINAL POLYPS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 77649219158     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp275     Document Type: Article

References (55)

1. Vogelstein, B. et al. (1988) Genetic alteration during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
2. Kinzler, K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
3. Moser, A.R. et al. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
4. Yang, K. et al. (1998) Dietary modulation in a mouse model for human familial adenomatous polyposis. Cancer Res., 58, 5713-5717.
5. Sica, V. et al. (1984) Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res., 44, 4670-4674.
6. Francavilla, A. et al. (1987) Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology, 93, 1301-1306.
7. Di Leo, A. et al. (1994) Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig. Dis. Sci., 39, 2038-2042.
8. Fernandez, E. et al. (1998) Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol. Biomarkers Prev., 7, 329-333.
9. Notarnicola, M. et al. (2001) Oestrogen receptors and microsatellite instability in colorectal cancer patients. Cancer Lett., 168, 65-70.
10. Woodson, K. et al. (2001) Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. Report J. Natl Cancer Inst., 93, 1799-1805.
11. Newcomb, P.A. et al. (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA, 110, 219-227.
12. Pettersson, K. et al. (2000) Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene, 19, 4970-4978.
13. Lindberg, M.K. et al. (2003) Estrogen receptor (ER)-beta reduces ERalpharegulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol. Endocrinol., 17, 203-208.
14. Gustafsson, J.A. (1999) Estrogen receptor b: a new dimension in estrogen mechanism of action. J. Endocrinol., 163, 379-383.
15. Giroux, V. et al. (2008) Estrogen receptor beta/deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice. Int. J. Cancer, 123, 303-311.
16. Javid, S.H. et al. (2005) Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer. Carcinogenesis, 26, 587-595.
17. Weyant, M.J. et al. (2001) Reciprocal expression of ERα and ERβ is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res., 61, 2547-2551.
18. Bardin, A. et al. (2004) Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer, 11, 537-551.
19. Jassam, N. et al. (2005) Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol. Rep., 14, 17-21.
20. Kennelly, R. et al. (2008) Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol., 9, 385-391.
21. Di Leo, A. et al. (2008) ER-beta expression in large bowel adenomas: implications in colon carcinogenesis. Dig. Liv. Dis., 40, 260-266.
22. Polyak, S.J. et al. (2007) Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCVinfection by standardized Silymarin. Gastroenterology, 132, 1925-1936.
23. Seidlova-Wuttke, D. et al. (2003) Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. J. Steroid Biochem. Mol. Biol., 86, 179-188.
24. Volate, S.R. et al. (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis, 26, 1450-1456.
25. Agarwal, R. et al. (2006) Anticancer potential of silymarin: from bench to bed side. Anticancer Res., 26, 4457-4498.
26. Singh, R.P. et al. (2008) Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res., 68, 2043-2050.
27. Harris, P.Q. et al. (1993) Dietary fibre: its composition and role in protection against colorectal cancer. Mutat Res., 290, 97-110.
28. Levi, F. et al. (2001) Dietary fibre and the risk of colorectal cancer. Eur. J. Cancer, 37, 2091-2096.
29. Harris, P.J. et al. (1996) The adsorption of heterocyclic aromatic amines by model dietary fibers with contrasting compositions. Chem. Biol. Interact., 100, 13-25.
30. Barone, M. et al. (2002) Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. Scand. J. Gastroenterol., 37, 88-94.
31. Begum, A.N. et al. (2004) Dietary lignins are precursors of mammalian lignans in rats. J. Nutr., 134, 120-127.
32. Mueller, S.O. et al. (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells. Toxicol. Sci., 80, 14-25.
33. Kuijsten, A. et al. (2006) Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., 15, 1132-1136.
34. Touillaud, M.S. et al. (2007) Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J. Natl Cancer Inst., 99, 475-486.
35. Mai, V. et al. (2003) Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res., 63, 1752-1755.
36. Coleman, L.J. et al. (2002) A diet containing α-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoximethane-treated rats. J. Nutr., 132, 2312-2318.
37. Itzkowitz, S.H. et al. (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology, 126, 1634-1648.
38. Ochiai, M. et al. (1996) DNA adduct formation, cell proliferation, and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis, 17, 95-98.
39. Caiazza, F. et al. (2007) 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem. Biophys. Res. Commun., 359, 102-107.
40. Raju, J. et al. (2009) Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-β. J. Nutr., 139, 474-481.
41. Wada-Hiraike, O. et al. (2006) New developments in oestrogen signalling in colonic epithelium. Biochem. Soc. Trans., 34, 1114-1116.
42. Acconcia, F. et al. (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J. Cell. Physiol., 203, 193-201.
43. Castiglione, F. et al. (2009) Expression of Estrogen receptor β in colon cancer progression. Diagn. Mol. Pathol., 17, 231-236.
44. Kohno, H. et al. (2002) Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int. J. Cancer, 101, 461-468.
45. Katiyar, S.K. et al. (2005) Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome release, and caspase activation. Mol. Cancer Ther., 4, 207-216.
46. Hogan, F.S. et al. (2007) Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest oh human colon cancer. J. Surg. Res., 143, 58-65
47. Labaj, J. et al. (2003) Reduction of genotoxic effects of the carcinogen N-methyl-N'-Nitro-N-nitrosoguanidine by dietary lignin in mammalian cells cultured in vitro. Nutr. cancer, 47, 95-103.
48. Danbara, N. et al. (2005) Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res., 25, 2269-2276.
49. Qu, H. et al. (2005) Lignans are involved in the antitumor activity of wheat bran in colon cancer SW480 cells. J. Nutr., 135, 598-602.
50. Cho, N.L. et al. (2007) Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/ + mice. Cancer Res., 67, 2366-2372.
51. Kouzmenko, A.P. et al. (2008) Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli. Genes Cells, 13, 723- 730.
52. Lim, C.H. et al. (2003) Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut, 52, 1127-1132.
53. Johnson, I.T. (2002) Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem. Toxicol., 40, 1171-1178.
54. Ohigashi, H. et al. (2004) Cancer prevention with food factors: alone and in combination. BioFactors, 22, 49-55.
55. Jen, J. et al. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.